Lipicare Pharmaceuticals
Eye Drops in Micro-emulsion Technology
Company Overview
Snapshot
Founded in June 2016, Lipicare Pharmaceuticals operates with 1–10 employees. The company has secured funding across one round from one investor, BIOLIGHT Life Sciences. A key milestone for the company was the signing of a manufacturing and distribution agreement in Europe for its product in July 2021.
Business overview
Lipicare Pharmaceuticals specializes in developing products based on nano-emulsions of phospholipids, designed to effectively deliver fatty medications to the ocular surface. The company's core product, Ocular D, is an eye drop for treating dryness, integrated with vitamin D, and is currently undergoing development with subcontractors. Lipicare Pharmaceuticals serves the healthcare and life sciences sectors, focusing on pharmaceuticals and drug delivery, with a primary market in Europe.
Strategic signal
In July 2021, Lipicare Pharmaceuticals secured a manufacturing and distribution agreement in Europe for its product. This strategic move signals the company's intent to commercialize its nano-emulsion technology, particularly Ocular D, and indicates progress towards market entry and expansion within the European ophthalmology market.
Company Intelligence Q&A
- When was Lipicare Pharmaceuticals founded?
- Lipicare Pharmaceuticals was founded in June 2016.
- What is Lipicare Pharmaceuticals' primary product?
- Lipicare Pharmaceuticals' primary product is Ocular D, an eye drop designed to treat dry eyes with integrated vitamin D, based on nano-emulsion technology.
- What was a significant development for Lipicare Pharmaceuticals in July 2021?
- In July 2021, Lipicare Pharmaceuticals signed a manufacturing and distribution agreement in Europe for its product, which helps alleviate symptoms related to screen exposure.
- Which investor participated in Lipicare Pharmaceuticals' funding round?
- In December 2019, BIOLIGHT Life Sciences participated as a lead investor in.
- What is the focus of Lipicare Pharmaceuticals' technology?
- Lipicare Pharmaceuticals focuses on developing products using nano-emulsions of phospholipids to deliver fatty medications to the ocular surface effectively and comfortably.